Journal of Analytical Toxicology
October 1, 2015
L. M. Lowe, Brianna L Peterson, Fiona J. Couper
This case was submitted to the Washington State Patrol Toxicology Laboratory in September 2014. A 15-year-old male went to a party where he ingested 25I-NBOMe and mushrooms. A short time later, he started to vomit and began seizing until he eventually passed out. Resuscitation efforts were made, but were unsuccessful. He was transported to a local hospital, where he died three days later of...
Drug and Alcohol Dependence
September 1, 2015
Gaël Le Roux, Chloé Bruneau, Benedicte Lelievre et al.
Over the last decade, use of phenethylamines has become increasingly prevalent. This study aimed to describe typical aspects of phenethylamine poisoning in order to better inform patient care. Phenethylamine poisoning cases reported to the Poison Control Center of Angers, France, from January, 2007 to December, 2013 were examined. Clinical findings were examined in 105 patients, including...
Neuropharmacology
August 2015
A Vigolo, Andrea Ossato, Claudio Trapella et al.
JWH-018 is a synthetic CB1 and CB2 agonist illegally marketed as products named "Spice" or "herbal blend" for its psychoactive effects which are much higher than those produced by cannabis. In the last year, the European Monitoring Centre for Drugs and Drug Addiction reported to the Italian National Early Warning System the seizure of plant material containing new halogenated derivatives of...
American Journal of Health-System Pharmacy
August 1, 2015
Kevin Betthauser, Jeffrey Pilz, Laura E Vollmer
Published evidence regarding the use of cannabis and cannabis derivatives by military veterans with posttraumatic stress disorder (PTSD) is reviewed. When inhaled or delivered orally or transdermally, cannabinoids (the psychoactive components of unrefined marijuana and various derivative products) activate endogenous cannabinoid receptors, modulating neurotransmitter release and producing a...
Neuropharmacology
August 2015
Tomohiko Irie, Ruri Kikura-Hanajiri, Makoto Usami et al.
Herbal products containing synthetic cannabinoids-initially sold as legal alternatives to marijuana-have become major drugs of abuse. Among the synthetic cannabinoids, [1-(5-fluoropentyl)-1H-indol-3-yl](4-methyl-1-naphthalenyl)-methanone (MAM-2201) has been recently detected in herbal products and has psychoactive and intoxicating effects in humans, suggesting that MAM-2201 alters brain...
Social Psychiatry and Psychiatric Epidemiology
June 1, 2015
Matthias Michal, Eva Duven, Sebastian Giralt et al.
Depersonalization (DP) involves unpleasant experiences of detachment from one's sense of self or unreality in the environment. DP may occur in a broad range of conditions, among healthy persons due to sleep loss, drug induced, secondary to anxiety disorders or primary in depersonalization disorder. Although DP has an early age of onset, little is known about the prevalence and correlates of DP...
Clinical Toxicology
May 8, 2015
Anders Helander, O. Beck, Matilda Bäckberg
BACKGROUND: Diphenidine (1-(1,2-diphenylethyl)piperidine) and its 2-methoxylated derivative methoxphenidine (MXP, 2-MeO-diphenidine) are substances with dissociative effects that were recently introduced for "recreational" purpose through the online-based sale of new psychoactive substances (NPS). A number of analytically confirmed non-fatal intoxications associated with diphenidine or MXP have...
Psychopharmacology
May 2015
C A Roberts, C Montgomery
Ecstasy use is associated with cognitive impairment, believed to result from damage to 5-HT axons. Neuroimaging techniques to investigate executive dysfunction in ecstasy users provide a more sensitive measure of cognitive impairment than behavioural indicators. The present study assessed executive access to semantic memory in ecstasy polydrug users and non-users. Twenty ecstasy polydrug users...
Neurology
April 6, 2015
Thananan Thammongkolchai, Pichet Termsarasab, Ayham Alkhachroum et al.
43 citations
Objective: To report the first case of myoclonus as neurologic presentation of 5-MeO-DALT abuse Background: 5-Meo-DALT (N,N-diallyl-5-methoxytryptamine) is a relatively new hallucinogen, initially sold online in 2004. It is a psychedelic compound from the tryptamine family which affects monoamine neurotransmitters including dopamine and serotonin. It is a psychostimulant with strong visual...
Revista de Fomento Social
March 4, 2015
Niranjan Chandra Shah
10 citations
Soma plant has been a mystery since a long time.A number of plants were proposed as Soma in the past by various authorities.Wasson (1968) proposed and claimed with a specific approach that Amanita muscaria, a mushroom was the Soma of the gveda.The juice of it was used as Soma drink.The Vedic Āryas (earlier called 'Vedic Āryans'), were the composer of gveda.They used to compose hymns (mantras)...